Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase

被引:4
|
作者
Lederhofer, Julia [1 ]
Tsybovsky, Yaroslav [2 ]
Nguyen, Lam [1 ]
Raab, Julie E. [1 ]
Creanga, Adrian [1 ]
Stephens, Tyler [2 ]
Gillespie, Rebecca A. [1 ]
Syeda, Hubza Z. [1 ]
Fisher, Brian E. [1 ]
Skertic, Michelle [1 ]
Yap, Christina [1 ]
Schaub, Andrew J. [1 ]
Rawi, Reda [1 ]
Kwong, Peter D. [1 ]
Graham, Barney S. [1 ,5 ]
Mcdermott, Adrian B. [1 ,6 ]
Andrews, Sarah F. [1 ]
King, Neil P. [3 ,4 ]
Kanekiyo, Masaru [1 ]
机构
[1] Natl Inst Allergy & Infect Dis, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Natl Canc Inst, Vaccine Res Ctr Electron Microscopy Unit, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA
[3] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[4] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA
[5] Morehouse Sch Med, Atlanta, GA 30310 USA
[6] Sanofi, F-69007 Lyon, France
关键词
Protective antigenic site; HEMAGGLUTININ-NEURAMINIDASE; ACTIVE-SITE; VALIDATION; INFECTION; ANTIGENICITY; EVOLUTION; TOOLS; CELLS;
D O I
10.1016/j.immuni.2024.02.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Continuously evolving influenza viruses cause seasonal epidemics and pose global pandemic threats. Although viral neuraminidase (NA) is an effective drug and vaccine target, our understanding of the NA antigenic landscape still remains incomplete. Here, we describe NA -specific human antibodies that target the underside of the NA globular head domain, inhibit viral propagation of a wide range of human H3N2, swine -origin variant H3N2, and H2N2 viruses, and confer both pre- and post -exposure protection against lethal H3N2 infection in mice. Cryo-EM structures of two such antibodies in complex with NA reveal non -overlapping epitopes covering the underside of the NA head. These sites are highly conserved among N2 NAs yet inaccessible unless the NA head tilts or dissociates. Our findings help guide the development of effective countermeasures against ever-changing influenza viruses by identifying hidden conserved sites of vulnerability on the NA underside.
引用
收藏
页码:574 / 586.e7
页数:21
相关论文
共 50 条
  • [41] Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice
    Gilchuk, Iuliia M.
    Bangaru, Sandhya
    Gilchuk, Pavlo
    Irving, Ryan P.
    Kose, Nurgun
    Bombardi, Robin G.
    Thornburg, Natalie J.
    Creech, C. Buddy
    Edwards, Kathryn M.
    Li, Sheng
    Turner, Hannah L.
    Yu, Wenli
    Zhu, Xueyong
    Wilson, Ian A.
    Ward, Andrew B.
    Crowe, James E., Jr.
    CELL HOST & MICROBE, 2019, 26 (06) : 715 - +
  • [42] Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells
    Smet, Anouk
    Catani, Joao Paulo Portela
    Ysenbaert, Tine
    Goncalves, Amanda
    Kleanthous, Harry
    Vogel, Thorsten U.
    Saelens, Xavier
    Job, Emma R.
    PLOS ONE, 2022, 17 (01):
  • [43] MONOCLONAL-ANTIBODIES FOR THE CONTROL OF INFLUENZA VIRUS VACCINES
    VANDEDONK, HJM
    DEJONG, JC
    VANOLDEREN, MF
    OSTERHAUS, ADME
    DEVELOPMENTS IN BIOLOGICALS, 1984, 57 : 251 - 255
  • [44] Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans
    Holzer, Barbara
    Rijal, Pramila
    McNee, Adam
    Paudyal, Basudev
    Martini, Veronica
    Clark, Becky
    Manjegowda, Tanuja
    Salguero, Francisco J.
    Bessell, Emily
    Schwartz, John C.
    Moffat, Katy
    Pedrera, Miriam
    Graham, Simon P.
    Noble, Alistair
    Bonnet-Di Placido, Marie
    La Ragione, Roberto M.
    Mwangi, William
    Beverley, Peter
    McCauley, John W.
    Daniels, Rodney S.
    Hammond, John A.
    Townsend, Alain R.
    Tchilian, Elma
    PLOS PATHOGENS, 2021, 17 (03)
  • [45] In Vivo Bioluminescent Imaging of Influenza A Virus Infection and Characterization of Novel Cross-Protective Monoclonal Antibodies
    Heaton, Nicholas S.
    Leyva-Grado, Victor H.
    Tan, Gene S.
    Eggink, Dirk
    Hai, Rong
    Palese, Peter
    JOURNAL OF VIROLOGY, 2013, 87 (15) : 8272 - 8281
  • [46] Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines
    Sangesland, Maya
    Lingwood, Daniel
    VACCINES, 2021, 9 (02) : 1 - 20
  • [47] CRYSTALLINE MONOCLONAL FAB FRAGMENT WITH SPECIFICITY TOWARDS AN INFLUENZA-VIRUS NEURAMINIDASE
    COLMAN, PM
    GOUGH, KH
    LILLEY, GG
    BLAGROVE, RJ
    WEBSTER, RG
    LAVER, WG
    JOURNAL OF MOLECULAR BIOLOGY, 1981, 152 (03) : 609 - 614
  • [48] NEUTRALIZATION OF NEWCASTLE-DISEASE VIRUS BY MONOCLONAL-ANTIBODIES TO THE HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN - REQUIREMENT FOR ANTIBODIES TO 4 SITES FOR COMPLETE NEUTRALIZATION
    IORIO, RM
    BRATT, MA
    JOURNAL OF VIROLOGY, 1984, 51 (02) : 445 - 451
  • [49] Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
    Wrammert, Jens
    Smith, Kenneth
    Miller, Joe
    Langley, William A.
    Kokko, Kenneth
    Larsen, Christian
    Zheng, Nai-Ying
    Mays, Israel
    Garman, Lori
    Helms, Christina
    James, Judith
    Air, Gillian M.
    Capra, J. Donald
    Ahmed, Rafi
    Wilson, Patrick C.
    NATURE, 2008, 453 (7195) : 667 - U10
  • [50] Human monoclonal single chain antibodies (HuScFv) that bind to the polymerase proteins of influenza A virus
    Thathaisong, Urnaporn
    Maneewatch, Santi
    Kulkeaw, Kasern
    Thueng-In, Kanyarat
    Poungpair, Ornutcha
    Srimanote, Potjanee
    Songserm, Thaweesalk
    Tongtawe, Pongsr
    Tapchaisri, Prairnuan
    Chaicurnpa, Wanpen
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2008, 26 (01): : 23 - 35